Tiotropium in Patients with Bronchiectasis: A Prospective Cohort Study

ConclusionIn conclusion, prospective cohort study showed that tiotropium effectively ameliorated the annual decline in the FEV1, with a lower-risk rate of moderate exacerbations and prolonging the time to the first-time severe exacerbation in patients with bronchiectasis and airflow limitation.
Source: Lung - Category: Respiratory Medicine Source Type: research